Joseph Group Capital Management
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1910383
COLUMBUS, OH
Position in VRTX
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$5,342,827
+$647,906 QoQ
Shares Held
10,756
+2.3% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
2.33%
of 13F equity value
Holder Rank
#464
of 1,735 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Joseph Group Capital Management holds $5,352,180 across 2 Biotechnology names. VRTX ranks #1 (99.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
10,756 | $5,342,827 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
15 | $9,353 |
All Filings in VRTX
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,342,827 | 10,756 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $4,694,921 | 10,514 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $4,755,293 | 10,489 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $4,060,523 | 10,368 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $3,454,752 | 7,760 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $3,454,827 | 7,126 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $2,586,139 | 6,422 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $2,637,933 | 5,672 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $2,257,824 | 4,817 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $1,835,481 | 4,391 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,525,023 | 3,748 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,195,530 | 3,438 | Shares | Sole | 2023-11-13 | |
| No filing history on record for this holder in this stock. | ||||||